Tres Cantos, Spain

Yoel Kashman

This inventor holds 2 USPTO granted patents. Top assignee: Instituto Biomar, S.a.. Active years: 2002.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Yoel Kashman. Retrieved from https://idiyas.com/inventor/yoel-kashman-wayboq36

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

Average Co-Inventor Count = 4.0

ph-index = 2

Forward Citations = 10(Granted Patents)


Location History:

  • Tres Cantos, ES (2002)
  • Ramat Aviv, IL (2002)

Company Filing History:


Years Active: 2002

Loading Chart...
2 patents (USPTO):Explore Patents

Title: The Innovative Contributions of Yoel Kashman

Introduction

Yoel Kashman is a notable inventor based in Tres Cantos, Spain. He has made significant contributions to the field of chemistry, particularly in the development of novel cytotoxic compounds. With a total of two patents to his name, his work has garnered attention in the scientific community.

Latest Patents

Kashman's latest patents include the discovery of cytotoxic alkaloid derivatives, specifically Asmarine A and B, which have been isolated from the sponge Raspailia sp. These compounds are novel cytotoxic diterpene-alkaloids, and their structures have been established based on NMR data and confirmed by X-ray analysis. Additionally, he has worked on cytotoxic pyridoacridine alkaloids, further showcasing his expertise in the field.

Career Highlights

Kashman is affiliated with Instituto Biomar, S.A., where he continues to push the boundaries of research in alkaloid chemistry. His work has implications for the development of new therapeutic agents, particularly in the fight against cancer.

Collaborations

Some of his notable coworkers include Dolores Garcia Gravalos and Amira Rudi, who have collaborated with him on various research projects.

Conclusion

Yoel Kashman's innovative work in the field of cytotoxic compounds highlights his significant contributions to science and medicine. His patents reflect a commitment to advancing knowledge and developing new therapeutic options.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…